Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Improper Labeling and Storage of Controlled Medications

Marshall, Michigan Survey Completed on 05-29-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Facility staff failed to ensure that controlled medications were properly labeled and stored according to professional standards. A resident, an 84-year-old female with diagnoses including chronic obstructive pulmonary disease, pneumonia, weakness, and depression, was admitted on hospice services and brought Lorazepam 0.5mg tablets from home. Instead of keeping the medication in its original pharmacy packaging, staff repackaged the tablets into nine unlabeled clear plastic bags and a cup, with no resident name, medication name, directions, or description on the packaging. The repackaging was done to facilitate counting at shift change, but staff were unable to identify the tablets by appearance, and the original labeled bottle was empty. Both the RN and DON confirmed the presence of the repackaged, unlabeled controlled medication and were unsure who authorized the repackaging. Interviews with nursing staff revealed that the standard practice was to keep all narcotic medications in their original, clearly labeled pharmacy packaging. However, in this instance, the controlled medication was divided into multiple unlabeled bags, and the staff responsible for this action could not be identified. The facility's documentation showed the medication was received from a home supply and that counts were being performed at shift changes, but the lack of proper labeling and storage did not meet professional standards or regulatory requirements.

An unhandled error has occurred. Reload 🗙